| Device Classification Name |
Test, Antigen, Nuclear, Epstein-Barr Virus
|
| 510(k) Number |
K233605 |
| Device Name |
ADVIA Centaur EBV-EBNA IgG |
| Applicant |
| Biokit, S.A. |
| Av. Can Montcau, 7 |
|
Lliçà D’Amunt, Barcelona,
ES
08186
|
|
| Applicant Contact |
Dominique Monferrer |
| Correspondent |
| Biokit, S.A. |
| Av. Can Montcau, 7 |
|
Lliçà D’Amunt, Barcelona,
ES
08186
|
|
| Correspondent Contact |
Dominique Monferrer |
| Regulation Number | 866.3235 |
| Classification Product Code |
|
| Subsequent Product Code |
|
| Date Received | 11/09/2023 |
| Decision Date | 08/07/2024 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Microbiology
|
| 510k Review Panel |
Microbiology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|